Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Ceccarelli

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
The Lancet. Oncology|February 12, 2022
Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort studyMohamad Saad, Younes Mokrab, Najeeb Halabi, et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2007
[Usefulness of a telematic system and image analysis in the follow-up of high-risk patients: a new health service model]Nicola De Luca, Raffaele Izzo, Francesco Rozza, et al.
Plos One|February 25, 2012
Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinaseMarianna Scrima, Carmela De Marco, Fernanda Fabiani, et al.
Developmental Biology|September 20, 2011
Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterningHenrik Fagman, Elena Amendola, Luca Parrillo, et al.
Oncotarget|May 31, 2022
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cellsIlaria Guerriero, Daniela D'Angelo, Pierlorenzo Pallante, et al.
Journal of Translational Medicine|April 18, 2024
Mutational landscape of inflammatory breast cancerFrançois Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Oncotarget|November 24, 2016
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cellsIlaria Guerriero, Daniela D'Angelo, Pierlorenzo Pallante, et al.
Frontiers in Physiology|March 30, 2018
3,5-Diiodo-L-Thyronine Affects Structural and Metabolic Features of Skeletal Muscle Mitochondria in High-Fat-Diet Fed Rats Producing a Co-adaptation to the Glycolytic Fiber PhenotypeElena Silvestri, Federica Cioffi, Rita De Matteis, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Journal of Translational Medicine|September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerAlice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|February 12, 2022
Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort studyMohamad Saad, Younes Mokrab, Najeeb Halabi, et al.
Giornale Italiano Di Cardiologia (2006)|May 18, 2007
[Usefulness of a telematic system and image analysis in the follow-up of high-risk patients: a new health service model]Nicola De Luca, Raffaele Izzo, Francesco Rozza, et al.
Plos One|February 25, 2012
Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinaseMarianna Scrima, Carmela De Marco, Fernanda Fabiani, et al.
Developmental Biology|September 20, 2011
Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterningHenrik Fagman, Elena Amendola, Luca Parrillo, et al.
Oncotarget|May 31, 2022
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cellsIlaria Guerriero, Daniela D'Angelo, Pierlorenzo Pallante, et al.
Journal of Translational Medicine|April 18, 2024
Mutational landscape of inflammatory breast cancerFrançois Bertucci, Florence Lerebours, Michele Ceccarelli, et al.
Oncotarget|November 24, 2016
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cellsIlaria Guerriero, Daniela D'Angelo, Pierlorenzo Pallante, et al.
Frontiers in Physiology|March 30, 2018
3,5-Diiodo-L-Thyronine Affects Structural and Metabolic Features of Skeletal Muscle Mitochondria in High-Fat-Diet Fed Rats Producing a Co-adaptation to the Glycolytic Fiber PhenotypeElena Silvestri, Federica Cioffi, Rita De Matteis, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Journal of Translational Medicine|September 19, 2023
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancerAlice Mogenet, Pascal Finetti, Emilie Denicolai, et al.
Pageof 15